Inventor · disambiguated record
Angelica Sanabria
Also filed as: SANABRIA ANGELICA · SANABRIA ANGELICA N
8 granted patents·4 pending applications·4 citations·filing 2019–2025
77Inventor score
Top patents by PatentIndex Score
12 records- 0188US12043667B2CLEC12a binding polypeptides and uses thereofINHIBRX BIOSCIENCES INC·Filed 2020·Granted Jul 23, 2024·2 cites·27 claims
- 0287US11560428B2CD33-binding polypeptides and uses thereofINHIBRX INC·Filed 2020·Granted Jan 24, 2023·2 cites·37 claims
- 0381US12297271B2PD-1 single domain antibodies and therapeutic compositions thereofINHIBRX BIOSCIENCES INC·Filed 2024·Granted May 13, 2025·0 cites·18 claims
- 0477US2025059279A1CD33-Binding Polypeptides and Uses ThereofINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0576US2025011436A1CLEC12a Binding Polypeptides and Uses ThereofINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0673US12084502B2CD33-binding polypeptides and uses thereofINHIBRX BIOSCIENCES INC·Filed 2022·Granted Sep 10, 2024·0 cites·27 claims
- 0772US11945869B2PD-1 single domain antibodies and therapeutic compositions thereofINHIBRX INC·Filed 2021·Granted Apr 2, 2024·0 cites·17 claims
- 0872US11208485B2PD-1 single domain antibodies and therapeutic compositions thereofINHIBRX INC·Filed 2019·Granted Dec 28, 2021·0 cites·28 claims
- 0963US2025313623A1Dll3 single domain antibodies and therapeutic compositions thereofINHIBRX BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1061US12421315B2CLL-1 targeted immunotherapiesREGENERON PHARMA·Filed 2020·Granted Sep 23, 2025·0 cites·20 claims
- 1161US12365728B2DLL3 single domain antibodies and therapeutic compositions thereofINHIBRX BIOSCIENCES INC·Filed 2019·Granted Jul 22, 2025·0 cites·32 claims
- 1241US2023124851A1B7h3 single domain antibodies and therapeutic compositions thereofINHIBRX LNC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Angelica Sanabria files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →